Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Need some traders or chart guys on that one. Is this accumulation or black box?
Go ahead, shorty, make my day.
Looks like they made a good call just ahead of it.
They listed 3 biotech stocks that could have a big breakout
To the moon!!!
Agreed that shorts have good reason to be cautious. There's a very good chance of getting left in the dust. My original post was poorly worded. What I actually was referring to was no morning reversal period with MMs dropping the bid to cover their shorts.
CP, what do you think about the SP holding through the morning MM shorting period?
Hmm...somebody wants in. Big time.
Looks like somebody wants some shares. <EOM>
It's all in the financing now. If there is non-dilutive financing, SP takes off. If BOD/mgmt used fast track news to take performance pressure off themselves by selling into the news with an ATM, then there is nothing to see here for a long time. All imo, of course.
Price follows volume. EOM.
How about $1.45 on 1.8 million shares?
That is nice. But I'dd prefer to see us close at 1.42/1.43$ (if no news) then at 1.52$.
We need a slow and steady climb up otherwise the MM's are forced to bring us partially back down to make profits. If they short into demand they must buy back below that price to make a profit.
Wook,
If she runs, $75 is a reasonable target. The question is whether she ever runs again. And even if not, a transient spike to the $5 range is not out of the question. All IMHO, of course.
I don't think I'll make it to a million...unless I become the most amazing trading wookie EVER!!! Of course unless we hit $75 per share!!!
Price follows volume.
Too many call options at $1.50 and $2.00, so the crooks won't let this one run until they expire worthless. Only way we move up is with a partner or major investment firm being announced.
I'll settle for four million.
I perdict a gazzillion shares will trade today.
Inflation could bring $10+ if you wait long enough.
FDA approval could bring $10+
CP, Agreed. I believe the last big price movement had as much to do with the bank financing announcement as the trial results. If there is a similar reason for the market to believe that there will be no more dilution, the PPS takes off.
In the same style I don't expect this PIII announcement to be the underlying engine for push up but the rather the coming financing PR.
Can't seem to find anyplace to buy the Nov 2014 555 calls!!! They must be putting them aside for the privileged few.
I think the concern would be unquantified financial exposure. This could also be a concern for a bank.
I would be surprised if any bp's are really afraid of this bogus class action lawsuit that has already failed a couple of times, but who knows
So is the current status dismissed without prejudice and a drop dead date of January 22 to amend the complaint?
For the reasons above, the Court GRANTS Defendant’s motion to dismiss. Plaintiff may
amend his Complaint in accordance with the foregoing. Should Plaintiff choose to amend, he
must submit an amended complaint no later than January 22, 2014. Failure to file an amended
pleading by January 22, 2014 will result in dismissal of this action with prejudice.
A valid concern. I also wonder if they Abbvie may have told management to make the CA suit go away before they get on-board.
Could be that Abbvie got pissed about the wasted time and the way management handled the phase II situation. Announcing unprecedented data and revoking it two weeks later may not have sat well with them. Perhaps they weren't comfortable getting involved with a company run like this
Sorry...I meant the clinical trial, not the BS court case.
The question that I have is now that the trial appears to be back on track where is Abbvie and where is the bank financing?
So, no matter the fact that the dose switching incident has put those talking on a hold or maybe even totally to a stop, it proves PPHM was engaged in more then casual talks with at least one BP we now know off.
Four decimal place trades. Here we go again.
Who's got Level III? I bet all those large blocks today came pouring in from ShareBuilder.
Wook..
A quick move to $70 from here would not be unprecedented, without or without a tangible "catalyst" There is a LOT of volatility in small biotechs, and sometimes the price defies reason on the low and high side..all imho, of course.
skweze, personally, I don't agree with the reverse split valuation of $70. To me it was only $16ish...only the chart says it was worth that much at the time.
; )
I would take $70 now though. : )
Wook...at one time, the market thought the company was worth $70/share. Most or important or not, I'll settle for that valuation. ;)
skweze that all depends if PPHM is just any old little biotech or if PPHM has the most important biologic immunotherapy for the 21st Century.
We will know the answer to that in time...
Wook...I appreciate what you're suggesting, but could it also be possible that it's just hedge funds and market makers jerking with the share price because it's easy to jerk with the share price of basically any clinical stage biotech?
skweze...remember, this is merely hyperbole. I don't think the end game is to just get retail out...it is to completely control, own or stop ANY technology that would/could upset the apple cart. if most shares are being held firm they have effictively done what "they" can do without other intervention...like somehow having an article with Peregrine Pharmeceutical CEO attempts suicide and 200 Million(or whatever) is missing...when, in fact, The company was Peregrine Financial. WHOOPS....or the myriad of other bashing articles with half truths and innuendo.....
It is quite obvious, to me at least, that some entity does not want Peregrine to succeed.
That's my story and i'm sticking with it.
Okay, but how do "they" know they are taking "retail" shares off the street? What if "they" are just buying ATM shares? (which would contradict their alleged purpose by increasing the company's cash position.) Or what if the shares they are buying are MM inventory or MM shorts to fill orders? How many "retail" investors are going to dump their shares over a dime or a quarter price movement?
"they" are the entity that would lose the most IF IF IF Bavituximab and anti-PS were to upset the entire oncology and other serious disease market.
It's just fiction......or is it???????
Okay, but who are "they?" Retail shares are being transferred to whom?
"they" want to knock retail holders out.
So does that mean that all previous references to partnering have been merely lip service?
King says that partnering is a BIG PUSH!
Aren't most of the shares retail?
They want retail shares!
part of the problem is that there seems to be no reason given as to why one has to buy now.
$70 was the high in March of 2000. I believe you are forgetting to adjust for the split.
High was about 16 when it was TCLN, it may have hit 5.90 before Fargo. 70 you have the wrong stock.
But I am expeceting once the breakout occurs, there will be no turning back. Long overdue for massive upward reversal in PPS.
Not just a nickel
An interesting theory, but can't the current PPS also be attributed to the relatively anemic volume recently?
What if after PPHM changed Transfer Agents, they discovered key entities, possibly BP type or perhaps offshore brokers that the new Transfer Agent could prove were making large short trasnsactions... or simply dumping shares for a loss then rebuying at a lower price just to force the PPS to remain low.
Out of steam, and they're walking it down.
Deja vu all over again.
Okay...so PPHM was close to a partner before the dose switching debacle. But where is the partner now? If Abbive was interested then, they should have a line of big pharma suitors now that the FDA design approval is in hand. What is scaring potential partners away?
we know now for SURE that PPHM discussed partnering with Abbvie
Definitely intriguing. But the other question is how many shares were just traded back and forth by black box algos?
Another one on a similar note is "Who bought all of those 150,000,000 shares immediately after the September 24 fiasco?"
Intriguing.
If they can scare some longs out. But it looks like most of the long positions are dug in.
I don't know whether multiple bear raids qualifies for a negative catalyst or not.
Certainly unusual. But wouldn't you need a negative catalyst to break down at this point? It looks like the longs are holding fast.
Our track record has not been good breaking out of these tight bands in the past and lie I said this is the tightest and longest I have ever seen in pphm.